Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CAMP4 Therapeutics Corporation (CAMP) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CAMP4 Therapeutics Corporation (CAMP), most recent 12 months reported: revenue $4.22M, net loss $107.24M, free cash flow -$28.72M. Latest balance sheet on file: liquid cash $86.4M. From SEC filings. Others in Pharmaceutical Preparations: Bolt Biotherapeutics, Inc. · ENTRADA THERAPEUTICS, INC. · KYNTRA BIO, INC. · Ensysce Biosciences, Inc. · CHINA PHARMA HOLDINGS, INC. · ProPhase Labs, Inc. · MARKER THERAPEUTICS, INC. · NRX Pharmaceuticals, Inc.

Stock screener

Watchlist